A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis.
Yamato NagataShotaro AkibaHidekazu HoriuchiKazuo OkumotoShigemi HachinoheRintaro OhePublished in: Clinical journal of gastroenterology (2024)
A 66-year-old woman with rheumatoid arthritis (RA) who had been receiving methotrexate (MTX) for 2 years presented with tarry stools. Contrast-enhanced computed tomography (CT) of the abdomen revealed irregular wall thickening in the ileocecal region and multiple low-contrast masses in both lobes of the liver. Lower gastrointestinal endoscopy revealed a type 2 tumor in the ileocecal region with a semi-peripheral ulcer. Histological examination of liver and colon biopsies showed other iatrogenic immunodeficiency-associated lymphoproliferative disorder (Oi-LPD), diffuse large B-cell lymphoma type, with positivity for Epstein-Barr virus DNA. After withdrawal of MTX, the LPD lesions disappeared and the patient achieved remission. We considered this to be a sporadic case of Oi-LPD, diffuse large B-cell lymphoma type, in the liver and colon due to treatment with MTX. There has been no previous report of this condition with simultaneous hepatic and colonic lesions, and the present case is thought to be highly informative in relation to the pathogenesis.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- contrast enhanced
- computed tomography
- rheumatoid arthritis
- magnetic resonance imaging
- diffusion weighted
- disease activity
- magnetic resonance
- positron emission tomography
- dual energy
- diffusion weighted imaging
- case report
- ankylosing spondylitis
- single cell
- high dose
- systemic lupus erythematosus
- interstitial lung disease
- late onset
- systemic sclerosis
- combination therapy